🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
4,720 results for “eu”
MedicineActive substanceLicence holderStatus
Janumet 50 mg/850 mg film-coated tablets
EU/1/08/455/1-7
Sitagliptin phosphate, Metformin Hydrochloride Merck Sharp & Dohme BV,
Januvia 100 mg film-coated tablets
EU/1/07/383/13-18
Sitagliptin phosphate monohydrate Merck Sharp & Dohme BV
Januvia 25 mg film-coated tablets
EU/1/07/383/1-6
Sitagliptin phosphate monohydrate Merck Sharp & Dohme BV,
Januvia 50 mg film-coated tablets
EU/1/07/383/7-12
Sitagliptin phosphate monohydrate Merck Sharp & Dohme BV
Jardiance 10 mg film-coated tablets
EU/1/14/930/010-018
Empagliflozin Boehringer Ingelheim International GmbH
Jardiance 25 mg film-coated tablets
EU/1/14/930/001-009
Empagliflozin Boehringer Ingelheim International GmbH
Javlor 25 mg/mL concentrate for solution for infusion
EU/1/09/550/1-12
Vinflunine ditartrate Pierre Fabre Medicament
Jayempi 10 mg/ml oral suspension
EU/1/21/1557/001
Azathioprine Lipomed GmbH
Jaypirca 100 mg film-coated tablets
EU/1/23/1738/004-009
Pirtobrutinib Eli Lilly Nederland B.V.
Jaypirca 50 mg film-coated tablets
EU/1/23/1738/001-003
Pirtobrutinib Eli Lilly Nederland B.V.
JEMPERLI 500 mg concentrate for solution for infusion
EU/1/21/1538/001
Dostarlimab GlaxoSmithKline Trading Services Limited
Jentadueto 2.5 mg/1000 mg film-coated tablets
EU/1/12/780/015-028
Metformin, Linagliptin Boehringer Ingelheim International GmbH
Jentadueto 2.5 mg/850 mg film-coated tablets
EU/1/12/780/001-014
Linagliptin, Metformin Boehringer Ingelheim International GmbH
JERAYGO 12.5 mg film-coated tablets
EU/1/24/1818/001-002
Aprocitentan Idorsia Pharmaceuticals Deutschland GmbH
JERAYGO 25 mg film-coated tablets
EU/1/24/1818/003-004
Aprocitentan Idorsia Pharmaceuticals Deutschland GmbH
JEVTANA 60 mg concentrate and solvent for solution for infusion
EU/1/11/676/001
Cabazitaxel Sanofi Winthrop Industrie
Jinarc 15 mg tablets
EU/1/15/1000/001-002
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Jinarc 15 mg tablets + Jinarc 45 mg tablets
EU/1/15/1000/005-007
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Jinarc 30 mg tablets
EU/1/15/1000/003-004
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Jinarc 30 mg tablets + Jinarc 60 mg tablets
EU/1/15/1000/008-010
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Jinarc 30 mg tablets + Jinarc 90 mg tablets
EU/1/15/1000/011-013
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Jivi 1000 IU powder and solvent for solution for injection
EU/1/18/1324/003
DAMOCTOCOG ALFA PEGOL Bayer AG
Jivi 2000 IU powder and solvent for solution for injection
EU/1/18/1324/004
DAMOCTOCOG ALFA PEGOL Bayer AG
Jivi 250 IU powder and solvent for solution for injection
EU/1/18/1324/001
DAMOCTOCOG ALFA PEGOL Bayer AG
Jivi 3000 IU powder and solvent for solution for injection
EU/1/18/1324/005
DAMOCTOCOG ALFA PEGOL Bayer AG
Jivi 4000 IU powder and solvent for solution for injection
EU/1/18/1324/011-012
DAMOCTOCOG ALFA PEGOL Bayer AG
Jivi 500 IU powder and solvent for solution for injection
EU/1/18/1324/002
DAMOCTOCOG ALFA PEGOL Bayer AG
Jorveza 0.5 mg orodispersible tablets
EU/1/17/1254/007-011
Budesonide Dr. Falk Pharma GmbH
Jorveza 1 mg orodispersible tablets
EU/1/17/1254/001-005
Budesonide Dr. Falk Pharma GmbH
Jubbonti 60 mg solution for injection in pre-filled syringe
EU/1/24/1813/001
Denosumab Sandoz GmbH
Jubereq 120 mg solution for injection
EU/1/25/1921/001-003
Denosumab Accord Healthcare S.L.U.
Juluca 50 mg/25 mg film-coated tablets
EU/1/18/1282/001-002
Dolutegravir, Rilpivirine hydrochloride, Sodium starch glycolate ep, Iron oxide yellow (E172) ViiV Healthcare BV
Junod 60 mg solution for injection in pre-filled syringe
EU/1/25/1933/001
Denosumab Gedeon Richter Plc
Jylamvo 2 mg/ml oral solution
EU/1/17/1172/001
Methotrexate Oresund Pharma ApS
Jyseleca 100 mg film-coated tablets
EU/1/20/1480/001-002
Filgotinib maleate Alfasigma S.p.A
Jyseleca 200 mg film-coated tablets
EU/1/20/1480/003-004
Filgotinib maleate Alfasigma S.p.A
Kabiven emulsion for infusion
PA2059/045/003
Soya bean oil, Glucose monohydrate, Alanine, Arginine, Aspartic Acid Fresenius Kabi Deutschland GmbH Marketed
Kabiven Peripheral emulsion for infusion
PA2059/045/004
Soya bean oil, Alanine, Aspartic Acid, Glutamic acid, Glycine Fresenius Kabi Deutschland GmbH Marketed
Kadcyla 100 mg powder for concentrate for solution for infusion
EU/1/13/885/001
Trastuzumab emtansine Roche Registration GmbH
Kadcyla 160 mg powder for concentrate for solution for infusion
EU/1/13/885/002
Trastuzumab emtansine Roche Registration GmbH
Kaftrio 37.5 mg/25 mg/50 mg film-coated tablets
EU/1/20/1468/002
Ivacaftor, TEZACAFTOR, Elexacaftor Vertex Pharmaceuticals (Ireland) Limited
Kaftrio 60 mg/40 mg/80 mg granules in sachet
EU/1/20/1468/003
Elexacaftor, TEZACAFTOR, Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
Kaftrio 75 mg/50 mg/100 mg film-coated tablets
EU/1/20/1468/001
TEZACAFTOR, Ivacaftor, VX-445 Vertex Pharmaceuticals (Ireland) Limited
Kaftrio 75 mg/50 mg/100 mg granules in sachet
EU/1/20/1468/004
Elexacaftor, TEZACAFTOR, Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
Kaletra
EU/1/01/172/4-5,7-8
Lopinavir, Ritonavir AbbVie Deutschland GmbH & Co. KG
Kaletra (80 mg + 20 mg)/ml oral solution
EU/1/01/172/003
Ritonavir, Lopinavir AbbVie Deutschland GmbH & Co. KG
Kaletra 100 mg/25 mg film-coated tablets
EU/1/01/172/006
Ritonavir, Lopinavir AbbVie Deutschland GmbH & Co. KG
Kalydeco 13.4 mg granules in sachet
EU/1/12/782/010-011
Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
Kalydeco 150 mg film-coated tablets
EU/1/12/782/001-002
Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
Kalydeco 150 mg film-coated tablets
EU/1/12/782/005
Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
36 37 38 39 40 41 42
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.